Medicamen Biotech Limited (BOM:531146)
India · Delayed Price · Currency is INR 354.00
-10.60 (-2.91%)
At close: Jan 20, 2026
Medicamen Biotech Market Cap
Medicamen Biotech has a market cap or net worth of 4.48 billion as of January 23, 2026. Its market cap has decreased by -28.61% in one year.
Market Cap
4.48B
Enterprise Value
4.43B
Revenue
1.70B
Ranking
n/a
PE Ratio
47.33
Stock Price
354.00
Market Cap Chart
Since January 12, 2005, Medicamen Biotech's market cap has increased from 108.49M to 4.48B, an increase of 4,033.55%. That is a compound annual growth rate of 19.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 4.48B | -2.85% |
| Dec 31, 2025 | 4.62B | -28.94% |
| Dec 31, 2024 | 6.50B | -14.77% |
| Dec 29, 2023 | 7.62B | -27.09% |
| Dec 30, 2022 | 10.45B | -3.50% |
| Dec 31, 2021 | 10.83B | 86.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kopran | 6.56B |
| Kilitch Drugs (India) | 5.40B |
| Sudarshan Pharma Industries | 5.02B |
| Jenburkt Pharmaceuticals | 4.79B |
| Everest Organics | 4.03B |
| Medico Remedies | 4.03B |
| Albert David | 3.93B |
| ZIM Laboratories | 3.71B |